Mood-altering drugs and hyperkinetic children
Erenberg, G.
Pediatrics 49(2): 308-311
1972
ISSN/ISBN: 0031-4005 PMID: 5059542 Document Number: 55781
Document emailed within 1 workday
Related Documents
Penn, G.M. 1983: Attitudes in the U.S. toward alcohol and other mood altering drugs Journal of the Kansas Medical Society 84(7): 402-405Olsen, R. 1971: Pediatric practice: whose mood are we altering? Pediatrics 47(5): 961
Miller, P.H. 1976: Prescribing behavior altering drugs: dark clouds on the horizon Journal of the Tennessee Medical Association 69(10): 720-721
Clagett, G.P.; Zelenock, G.B.; Stanley, J.C.; Lindenauer, S.M.; Fry, W.J. 1973: Prevention of early vein graft thrombosis by drugs altering platelet function Surgical Forum 24: 253-254
Monti, A. 1971: Mood, behavior and drugs Minerva Medica 62(40): 33-34
Millar, F.A.; Mackenzie, A.; Hutchison, G.; Bannister, J. 1996: Hemostasis-altering drugs and central neural block. A survey of anesthetic practice in Scotland and the United Kingdom Regional Anesthesia 21(6): 529-533
Majdevac, Z. 1977: Hyperkinetic dysphonia in children Medicinski Pregled 30(9-10): 505-508
Lingjaerde, O. 1972: Psychostimulant treatment of "hyperkinetic" children Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 92(1): 34-35
Greenhill, L.L.; Puig-Antich, J.; Halpern, F.; Sachar, E.J.; Rubinstein, B.; Chambers, W.; Fiscina, B.; Florea, J. 1980: Growth disturbances in hyperkinetic children Pediatrics 66(1): 152-154
Rajna, P.ét. 2008: Antiepileptic drugs as mood stabilizers: what did we learn from the epileptology? Ideggyogyaszati Szemle 61(9-10): 305-316
Horwitz, D.L. 1980: Conspectus: food colorings and hyperkinetic children Comprehensive Therapy 6(11): 3-4
Hoffer, A. 1972: Treatment of hyperkinetic children with nicotinamide and pyridoxine Canadian Medical Association Journal 107(2): 111-112
Mel'nichuk, P.V.; Sosnovskaia, L.S.; Khaĭlova, I.M. 1975: Treatment of the hyperkinetic form of cerebral palsy in children Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 75(10): 1463-1467
Sukhotina, N.K.; Konovalova, V.V.; Kryzhanovskaia, I.L.; Kupriianova, T.A. 2010: Efficacy of pantogam in the treatment of hyperkinetic disorders in children Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(12): 24-28
Supácek, I. 1970: Pneumographic studies in the diagnosis of hyperkinetic dysphonia in children Monatsschrift für Ohrenheilkunde und Laryngo-Rhinologie 104(4): 168-172
Herling, S.; Woods, J.H. 1980: Chlorpromazine effects on cocaine-reinforced responding in rhesus monkeys: reciprocal modification of rate-altering effects of the drugs Journal of Pharmacology and Experimental Therapeutics 214(2): 354-361
Sukhotina, N.K. 2009: Elaboration of a patient management protocol for Hyperkinetic disorders in children and adolescents Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 109(4): 43-49
Goyette, G.H.; Connors, C.K.; Petti, T.A.; Curtis, L.E. 1978: Effects of artificial colors on hyperkinetic children: a double-blind challenge study Psychopharmacology Bulletin 14(2): 39-40
Rosenbaum, A.H.; Maruta, T.; Richelson, E. 1979: Series on pharmacology in practice: 1. Drugs that alter mood. I. Tricyclic agents and monoamine oxidase inhibitors Mayo Clinic Proceedings 54(5): 335-344
Helmeste, D.M.; Seeman, P. 1983: Genetic differences in brain dopamine receptors and amphetamine response: possible model for hyperkinetic children Progress in Clinical and Biological Research 135: 401-403